PARP inhibitors in primary and recurrent ovarian cancer


E-session 508

Expert
Mansoor Raza Mirza'
Rigshospitalet
Copenhagen, Denmark
Discussant
Mikkel Rosendahl'
Rigshospitalet
Copenhagen, Denmark

This e-Session is part of the following pathway(s):
12
Dec 2019